APA (7th ed.) Citation

Yu, J. C., Hlávka, J. P., Joe, E., Richmond, F. J., & Lakdawalla, D. N. Impact of non‐binding FDA guidances on primary endpoint selection in Alzheimer's disease trials. Wiley.

Chicago Style (17th ed.) Citation

Yu, Jeffrey C., Jakub P. Hlávka, Elizabeth Joe, Frances J. Richmond, and Darius N. Lakdawalla. Impact of Non‐binding FDA Guidances on Primary Endpoint Selection in Alzheimer's Disease Trials. Wiley.

MLA (9th ed.) Citation

Yu, Jeffrey C., et al. Impact of Non‐binding FDA Guidances on Primary Endpoint Selection in Alzheimer's Disease Trials. Wiley.